Skip to main content
Erschienen in: Breast Cancer 2/2014

01.03.2014 | Original Article

Anxiety, depression, and quality of life in German ambulatory breast cancer patients

verfasst von: Hendrikje Schleife, Christine Sachtleben, Carolyn Finck Barboza, Susanne Singer, Andreas Hinz

Erschienen in: Breast Cancer | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of the study was to determine the predictors of health-related quality of life in ambulatory breast cancer patients.

Methods

A total of 107 breast cancer outpatients were tested with the Hospital Anxiety and Depression Scale (HADS) and the quality of life instrument EORTC QLQ-C30. Furthermore, the degree of social support and shared decision making (SDM) were assessed.

Results

In nearly all domains of EORTC QLQ-C30 the patients reported worse mean scores than the general population in a clinically significant range, especially in the symptom scales. Therapy-related factors and the degree of SDM contributed only marginally to quality of life. Social support, however, proved to be predictive of better mental health and better quality of life in many domains.

Conclusion

Irrespective of the therapy, the social network of the patients should be activated to help the patients to cope with the disease. However, the findings do not support the idea that enhanced SDM would have beneficial effects on mental health.
Literatur
1.
Zurück zum Zitat Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2010;21:925–30.PubMedCrossRef Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2010;21:925–30.PubMedCrossRef
2.
Zurück zum Zitat Kramer JA, Curran D, Piccart M, De Haes JCJM, Bruning P, Klijn J, et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer. 2000;36:1498–506.PubMedCrossRef Kramer JA, Curran D, Piccart M, De Haes JCJM, Bruning P, Klijn J, et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer. 2000;36:1498–506.PubMedCrossRef
3.
Zurück zum Zitat Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D. Predictors of quality of life of breast cancer patients. Acta Oncol. 2003;42:710–8.PubMedCrossRef Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D. Predictors of quality of life of breast cancer patients. Acta Oncol. 2003;42:710–8.PubMedCrossRef
4.
Zurück zum Zitat Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. 2007;16:767–76.PubMedCrossRef Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. 2007;16:767–76.PubMedCrossRef
5.
Zurück zum Zitat Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer. 2004;40:673–80.PubMedCrossRef Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer. 2004;40:673–80.PubMedCrossRef
6.
Zurück zum Zitat Schou I, Ekeberg O, Sandvik L, Hjermstad MJ, Ruland CM. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 2005;14:1813–23.PubMedCrossRef Schou I, Ekeberg O, Sandvik L, Hjermstad MJ, Ruland CM. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 2005;14:1813–23.PubMedCrossRef
7.
Zurück zum Zitat Groenvold M, Fayers PM, Sprangers MAG, Bjorner JB, Klee MC, Aaronson NK, et al. Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol. 1999;52:523–30.PubMedCrossRef Groenvold M, Fayers PM, Sprangers MAG, Bjorner JB, Klee MC, Aaronson NK, et al. Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol. 1999;52:523–30.PubMedCrossRef
8.
Zurück zum Zitat Schwarz R, Krauss O, Hoeckel M, Meyer A, Zenger M, Hinz A. The course of anxiety and depression in patients with breast cancer and gynaecological cancer. Breast Care. 2008;3:417–22.PubMedCentralPubMedCrossRef Schwarz R, Krauss O, Hoeckel M, Meyer A, Zenger M, Hinz A. The course of anxiety and depression in patients with breast cancer and gynaecological cancer. Breast Care. 2008;3:417–22.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008;27:32. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008;27:32.
10.
Zurück zum Zitat Kornblith AB, Herndon JE, Zuckerman E, Viscoli CM, Horwitz RI, Cooper MR, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001;91:443–54.PubMedCrossRef Kornblith AB, Herndon JE, Zuckerman E, Viscoli CM, Horwitz RI, Cooper MR, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001;91:443–54.PubMedCrossRef
11.
Zurück zum Zitat Manning-Walsh J. Social support as a mediator between symptom distress and quality of life in women with breast cancer. JOGNN J Obst Gyn Neo. 2005;34:482–93.CrossRef Manning-Walsh J. Social support as a mediator between symptom distress and quality of life in women with breast cancer. JOGNN J Obst Gyn Neo. 2005;34:482–93.CrossRef
12.
Zurück zum Zitat Kraetschmer N, Sharpe N, Urowitz S, Deber RB. How does trust affect patient preferences for participation in decision-making? Health Expect. 2004;7:317–26.PubMedCrossRef Kraetschmer N, Sharpe N, Urowitz S, Deber RB. How does trust affect patient preferences for participation in decision-making? Health Expect. 2004;7:317–26.PubMedCrossRef
13.
Zurück zum Zitat O’Brien MA, Whelan TJ, Charles C, Ellis PM, Gafni A, Lovrics P, et al. Women’s perceptions of their treatment decision-making about breast cancer treatment. Patient Educ Couns. 2008;73:431–6.PubMedCrossRef O’Brien MA, Whelan TJ, Charles C, Ellis PM, Gafni A, Lovrics P, et al. Women’s perceptions of their treatment decision-making about breast cancer treatment. Patient Educ Couns. 2008;73:431–6.PubMedCrossRef
14.
Zurück zum Zitat Hinz A, Schwarz R. Anxiety and depression in the general population. A standardization study of the Hospital Anxiety and Depression Scale (in German with English abstract). Psychother Psychosom Med Psychol. 2001;51:193–200.PubMedCrossRef Hinz A, Schwarz R. Anxiety and depression in the general population. A standardization study of the Hospital Anxiety and Depression Scale (in German with English abstract). Psychother Psychosom Med Psychol. 2001;51:193–200.PubMedCrossRef
15.
Zurück zum Zitat Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37:1345–51.PubMedCrossRef Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37:1345–51.PubMedCrossRef
16.
Zurück zum Zitat Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef
17.
Zurück zum Zitat Singer S, Kuhnt S, Götze H, Hauss J, Hinz A, Liebmann A, et al. Hospital Anxiety and Depression Scale cut-off scores for cancer patients in acute care. Br J Cancer. 2009;100:908–12.PubMedCentralPubMedCrossRef Singer S, Kuhnt S, Götze H, Hauss J, Hinz A, Liebmann A, et al. Hospital Anxiety and Depression Scale cut-off scores for cancer patients in acute care. Br J Cancer. 2009;100:908–12.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care. 2010;19:522–9.CrossRef Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care. 2010;19:522–9.CrossRef
19.
Zurück zum Zitat Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A. The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res. 2010;69:371–8.PubMedCrossRef Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A. The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res. 2010;69:371–8.PubMedCrossRef
20.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.PubMedCrossRef
21.
Zurück zum Zitat Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50:441–50.PubMedCrossRef Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50:441–50.PubMedCrossRef
22.
Zurück zum Zitat Osoba D. What has been learned from measuring health-related quality of life in clinical oncology. Eur J Cancer. 1999;35:1565–70.PubMedCrossRef Osoba D. What has been learned from measuring health-related quality of life in clinical oncology. Eur J Cancer. 1999;35:1565–70.PubMedCrossRef
23.
Zurück zum Zitat Ogce F, Ozkan S, Baltalarli B. Psychosocial stressors, social support and socio-demographic variables as determinants of quality of life of Turkish breast cancer patients. Asian Pac J Cancer Prev. 2007;8:77–82.PubMed Ogce F, Ozkan S, Baltalarli B. Psychosocial stressors, social support and socio-demographic variables as determinants of quality of life of Turkish breast cancer patients. Asian Pac J Cancer Prev. 2007;8:77–82.PubMed
24.
25.
Zurück zum Zitat Vaglio J Jr, Conard M, Poston WS, O’Keefe J, Haddock CK, House J, et al. Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes. 2004;2:24. Vaglio J Jr, Conard M, Poston WS, O’Keefe J, Haddock CK, House J, et al. Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes. 2004;2:24.
Metadaten
Titel
Anxiety, depression, and quality of life in German ambulatory breast cancer patients
verfasst von
Hendrikje Schleife
Christine Sachtleben
Carolyn Finck Barboza
Susanne Singer
Andreas Hinz
Publikationsdatum
01.03.2014
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 2/2014
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-012-0378-6

Weitere Artikel der Ausgabe 2/2014

Breast Cancer 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.